Quarry LP’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPP
Quarry LP's RAPP Position: Q3 2026 in Review
Quarry LP opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 173 shares worth $5.81K. The stake represents ﹤0.01% of the portfolio and ranks #1574 among its holdings.
169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.
- Quarry LP held 173 shares of Rapport Therapeutics worth $5.81K as of Q3 2026.
- Rapport Therapeutics was a new Quarry LP position in Q3 2026.
- Rapport Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q3 2026, its #1574 holding.
- 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.
Based on Quarry LP's 13F filing for Q3 2026, filed 16 Nov 2026.